<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2020-3-3774</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-3774</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Ранние структурно-функциональные нарушения левого желудочка у молодых лиц с артериальной гипертонией: роль инсулинорезистентности</article-title><trans-title-group xml:lang="en"><trans-title>Early structural and functional left ventricular disorders in young patients with hypertension: a role of insulin resistance</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9503-9236</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шаварова</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Shavarova</surname><given-names>E. K.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шаварова Елена Курбановна — кандидат медицинских наук, доцент кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева</p><p>Москва</p><p>Web of Science ResearcherID <ext-link xlink:href="https://publons.com/researcher/S-7067-2016/" ext-link-type="uri">S-7067-2016</ext-link></p></bio><bio xml:lang="en"/><email xlink:type="simple">alisheva@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5873-1768</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кобалава</surname><given-names>Ж. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kobalava</surname><given-names>Zh. D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кобалава Жанна Давидовна — член-корреспондент РАН, доктор медицинских наук, профессор, заведующая кафедрой внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева, заведующая кафедрой внутренних болезней, кардиологии и клинической фармакологии</p><p>Москва</p><p>Web of Science ResearcherID <ext-link xlink:href="https://publons.com/researcher/S-3842-2016/" ext-link-type="uri">S-3842-2016</ext-link></p></bio><bio xml:lang="en"/><email xlink:type="simple">zkobalava@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4382-1397</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ежова</surname><given-names>Н. E.</given-names></name><name name-style="western" xml:lang="en"><surname>Yezhova</surname><given-names>N. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ежова Надежда Е. — аспирант кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева</p><p>Москва</p></bio><bio xml:lang="en"/><email xlink:type="simple">ezhova_n@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8121-9965</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хомова</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Khomova</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хомова Ирина А. — аспирант кафедры внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева</p><p>Москва</p></bio><bio xml:lang="en"/><email xlink:type="simple">hom_iren91@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5937-3042</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Баздырева</surname><given-names>Е. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Bazdyreva</surname><given-names>E. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Баздырева Елена И. — врач отделения функциональной диагностики</p><p>Москва</p></bio><bio xml:lang="en"/><email xlink:type="simple">elenabaz615@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО Российский университет дружбы народов</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ Городская клиническая больница им. В. В. Виноградова Департамента здравоохранения г. Москвы</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.V. Vinogradov City Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>06</day><month>03</month><year>2020</year></pub-date><volume>25</volume><issue>3</issue><fpage>3774</fpage><lpage>3774</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шаварова Е.К., Кобалава Ж.Д., Ежова Н.E., Хомова И.А., Баздырева Е.И., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Шаварова Е.К., Кобалава Ж.Д., Ежова Н.E., Хомова И.А., Баздырева Е.И.</copyright-holder><copyright-holder xml:lang="en">Shavarova E.K., Kobalava Z.D., Yezhova N.E., Khomova I.A., Bazdyreva E.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/3774">https://russjcardiol.elpub.ru/jour/article/view/3774</self-uri><abstract><p>Ремоделирование миокарда относится к факторам, повышающим риск сердечно-сосудистых событий у лиц с артериальной гипертонией (АГ). Структурно-функциональные изменения миокарда могут быть следствием не только отчетливого влияния гемодинамических причин, но и ряда метаболических нарушений.</p><sec><title>Цель</title><p>Цель. Анализ ассоциаций инсулинорезистентности и ремоделирования левого желудочка (ЛЖ) в когорте молодых пациентов с нелеченой неосложненной АГ и высоким нормальным артериальным давлением (АД).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В когортное поперечное исследование включено 105 человек, у которых проанализированы клинико-демографические, антропометрические характеристики, выполнены биохимический анализ крови (креатинин, калий, липидный спектр, глюкоза, инсулин, мочевая кислота) с расчетом индексов инсулинорезистентности (HOMA-IR, METs-IR, TyG), анализ крови на гликированный гемоглобин, определяли соотношение альбумина/креатинина в разовой порции мочи. Всем обследованным измеряли офисное АД, выполняли суточное мониторирование АД, эхокардиографию с технологией 2D-спекл трекинг.</p></sec><sec><title>Результаты</title><p>Результаты. Медиана возраста составила 23 года, 85% мужчин. Избыточную массу тела или ожирение имели 51%, 39% — дислипидемию, 21% — инсулинорезистентность. Признаки ремоделирования ЛЖ наблюдались у 38 (40%) обследованных, из них у 32 (34%) — концентрическое ремоделирование, у 5 (5%) — концентрическая гипертрофия ЛЖ (ГЛЖ), у 1 (1%) — эксцентрическая ГЛЖ, нарушение глобального продольного систолического стрейна ЛЖ у 44 (47%) лиц молодого возраста с АГ и предгипертонией. При ступенчатом многофакторном регрессионном анализе независимым предиктором нарушения глобальной продольной деформации ЛЖ оказался индекс TyG (b=0,38, p=0,001).</p></sec><sec><title>Заключение</title><p>Заключение. В когорте молодых лиц с АГ и высоким нормальным АД отмечается высокая частота как инсулинорезистентности, метаболических нарушений, так и ранних признаков ремоделирования ЛЖ и субклинического снижения его систолической функции. Индекс TyG, доступный для расчета на основании рутинного биохимического обследования, является независимым фактором, влияющим на глобальную продольную деформацию ЛЖ.</p></sec></abstract><trans-abstract xml:lang="en"><p>Cardiac remodeling refers to factors that increase the risk of cardiovascular events in patients with hypertension (HTN). Changes in myocardial structure and function can be caused not only by hemodynamic causes, but also a number of metabolic disorders.</p><sec><title>Aim</title><p>Aim. To analyze the associations of insulin resistance and left ventricular (LV) remodeling in a cohort of young patients with untreated uncomplicated hypertension and high normal blood pressure (BP).</p></sec><sec><title>Material and methods</title><p>Material and methods. The presented cohort cross-sectional study included 105 subjects. We analyzed clinical, demographic and anthropometric characteristics, performed a biochemical panel (creatinine, potassium, lipid profile, glucose, insulin, uric acid) with the estimation of insulin resistance scores (HOMA-IR, METs-IR, TyG), a glycosylated hemoglobin test. Urine albumin-to-creatinine ratio was determined. Office and 24-hour ambulatory BP measurement and two-dimensional speckletracking echocardiography were performed in all patients.</p></sec><sec><title>Results</title><p>Results. The median age was 23 years (men — 85%); 51% of participants were overweight or obese, 39% had dyslipidemia, 21% — insulin resistance. Signs of LV remodeling were observed in 38 (40%) subjects: 32 (34%) — concentric remodeling, 5 (5%) — concentric LV hypertrophy (LVH), 1 (1%) — eccentric LVH. Defects of LV systolic global longitudinal strain (GLS) were observed in 44 (47%) young patients with HTN and preHTN. Stepwise multivariate regression analysis revealed that the TyG index was an independent predictor of LV GLS defects (b=0,38, p=0,001).</p></sec><sec><title>Conclusion</title><p>Conclusion. In a cohort of young patients with HTN and high normal blood pressure, there is a high prevalence of insulin resistance, metabolic disorders, and early signs of LV remodeling and subclinical systolic dysfunction. The TyG index, available for estimation by routine biochemical tests, is an independent factor affecting the LV GLS.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>артериальная гипертония</kwd><kwd>молодые</kwd><kwd>предгипертония</kwd><kwd>инсулинорезистентность</kwd><kwd>гипертрофия левого желудочка</kwd><kwd>нарушение деформации левого желудочка</kwd><kwd>глобальный продольный систолический стрейн левого желудочка</kwd><kwd>2D-спекл трекинг эхокардиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>hypertension</kwd><kwd>young patients</kwd><kwd>prehypertension</kwd><kwd>insulin resistance</kwd><kwd>left ventricular hypertrophy</kwd><kwd>left ventricular strain</kwd><kwd>left ventricular systolic global longitudinal strain</kwd><kwd>two-dimensional speckle-tracking echocardiography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Yano Y, Reia JP, Colangelo LA, et al. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life. JAMA. 2018;320(17):177482. doi:10.1001/jama.2018.13551.</mixed-citation><mixed-citation xml:lang="en">Yano Y, Reia JP, Colangelo LA, et al. Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life. JAMA. 2018;320(17):177482. doi:10.1001/jama.2018.13551.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Sullivan JM, Vander Zwaag RV, el-Zeky F, et al. Left ventricular hypertrophy: effect on survival. J. Am. Coll. Cardiol. 1993;22:508-13.</mixed-citation><mixed-citation xml:lang="en">Sullivan JM, Vander Zwaag RV, el-Zeky F, et al. Left ventricular hypertrophy: effect on survival. J. Am. Coll. Cardiol. 1993;22:508-13.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Mechanick JI, Garber AJ, Grunberger G, et al. Dysglycemia-based chronic disease: An American Association of Clinical Endocrinologists Position Statement. Endocr Pract. 2018;24:995-1011. doi:10.4158/PS-2018-0139.</mixed-citation><mixed-citation xml:lang="en">Mechanick JI, Garber AJ, Grunberger G, et al. Dysglycemia-based chronic disease: An American Association of Clinical Endocrinologists Position Statement. Endocr Pract. 2018;24:995-1011. doi:10.4158/PS-2018-0139.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Edvardsen T, Rosen BD, Pan L, et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging — the MultiEthnic Study of Atherosclerosis (MESA) Am Heart J. 2006;151:109-14.</mixed-citation><mixed-citation xml:lang="en">Edvardsen T, Rosen BD, Pan L, et al. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging — the MultiEthnic Study of Atherosclerosis (MESA) Am Heart J. 2006;151:109-14.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Matthews DR. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.</mixed-citation><mixed-citation xml:lang="en">Matthews DR. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-9.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299-304. doi:10.1089/met.2008.0034.</mixed-citation><mixed-citation xml:lang="en">Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299-304. doi:10.1089/met.2008.0034.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bello-Chavolla O, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes. Eur J Endocrinol 2018;178(5):533-44. doi:10.1530/EJE-17-0883. Epub 2018 Mar 13.</mixed-citation><mixed-citation xml:lang="en">Bello-Chavolla O, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a Novel Score to Evaluate Insulin Sensitivity, Is Predictive of Visceral Adiposity and Incident Type 2 Diabetes. Eur J Endocrinol 2018;178(5):533-44. doi:10.1530/EJE-17-0883. Epub 2018 Mar 13.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.</mixed-citation><mixed-citation xml:lang="en">Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-8.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. JACC. 1992;19(7):1550-8.</mixed-citation><mixed-citation xml:lang="en">Ganau A, Devereux RB, Roman MJ, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. JACC. 1992;19(7):1550-8.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Negishi K, Negishi T, Kurosawa K, et al. Practical guidance in echocardiographic assessment of global longitudinal strain. JACC Cardiovasc Imaging. 2015;8(4):489-92. doi:10.1016/j.jcmg.2014.06.013. Epub 2014 Aug 13.</mixed-citation><mixed-citation xml:lang="en">Negishi K, Negishi T, Kurosawa K, et al. Practical guidance in echocardiographic assessment of global longitudinal strain. JACC Cardiovasc Imaging. 2015;8(4):489-92. doi:10.1016/j.jcmg.2014.06.013. Epub 2014 Aug 13.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sundstrom J, Neovius M, Tynelius P. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ. 2011;342:d643. doi:10.1136/bmj.d643.</mixed-citation><mixed-citation xml:lang="en">Sundstrom J, Neovius M, Tynelius P. Association of blood pressure in late adolescence with subsequent mortality: cohort study of Swedish male conscripts. BMJ. 2011;342:d643. doi:10.1136/bmj.d643.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Williams B. High blood pressure in young people and premature death. BMJ. 2011;342:d1104. doi:10.1136/bmj.d1104.</mixed-citation><mixed-citation xml:lang="en">Williams B. High blood pressure in young people and premature death. BMJ. 2011;342:d1104. doi:10.1136/bmj.d1104.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kishi S, Gidding SS, Reis JP, et al. Association of insulin resistance and glycemic metabolic abnormalities with LV structure and function in middle age: the CARDIA study. JACC Cardiovasc Imaging. 2017;10:105-14. doi:10.1016/j.jcmg.2016.02.033. Epub 2016 Aug 17.</mixed-citation><mixed-citation xml:lang="en">Kishi S, Gidding SS, Reis JP, et al. Association of insulin resistance and glycemic metabolic abnormalities with LV structure and function in middle age: the CARDIA study. JACC Cardiovasc Imaging. 2017;10:105-14. doi:10.1016/j.jcmg.2016.02.033. Epub 2016 Aug 17.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Vishram JK, Borglykke A, Andreasen AH, et al. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) project. Hypertension. 2012 Nov;60(5):1117-23. doi:10.1161/HYPERTENSIONAHA.112.201400. Epub 2012 Sep 24.</mixed-citation><mixed-citation xml:lang="en">Vishram JK, Borglykke A, Andreasen AH, et al. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) project. Hypertension. 2012 Nov;60(5):1117-23. doi:10.1161/HYPERTENSIONAHA.112.201400. Epub 2012 Sep 24.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Julius S, Nesbitt SD, Egan BM, et al. Hypertension Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blockers. N Engl J Med. 2006 Apr 20;354(16):1685-97. Epub 2006 Mar 14.</mixed-citation><mixed-citation xml:lang="en">Julius S, Nesbitt SD, Egan BM, et al. Hypertension Study Investigators. Feasibility of treating prehypertension with an angiotensin-receptor blockers. N Engl J Med. 2006 Apr 20;354(16):1685-97. Epub 2006 Mar 14.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Navarini S, Bellsham-Revell H, Chubb H, et al. Myocardial deformation measured by 3-Demensional speckle tracking in children and adolescents with systemic arterial hypertension. Hypertension. 2017 Dec;70(6):1142-1147. doi:10.1161/HYPERTENSIONAHA.117.09574. Epub 2017 Oct 30.</mixed-citation><mixed-citation xml:lang="en">Navarini S, Bellsham-Revell H, Chubb H, et al. Myocardial deformation measured by 3-Demensional speckle tracking in children and adolescents with systemic arterial hypertension. Hypertension. 2017 Dec;70(6):1142-1147. doi:10.1161/HYPERTENSIONAHA.117.09574. Epub 2017 Oct 30.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Sengupta SP, Caracciolo G, Thompson C, et al. Early impairment of left ventricular function in patients with systemic hypertension: New insights with 2-dimensional speckle tracking echocardiography. Indian Heart J. 2013 Jan-Feb;65(1):48-52. doi:10.1016/j.ihj.2012.12.009. Epub 2012 Dec 26.</mixed-citation><mixed-citation xml:lang="en">Sengupta SP, Caracciolo G, Thompson C, et al. Early impairment of left ventricular function in patients with systemic hypertension: New insights with 2-dimensional speckle tracking echocardiography. Indian Heart J. 2013 Jan-Feb;65(1):48-52. doi:10.1016/j.ihj.2012.12.009. Epub 2012 Dec 26.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006 May;47(5):846-53. Epub 2006 Mar 27.</mixed-citation><mixed-citation xml:lang="en">Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006 May;47(5):846-53. Epub 2006 Mar 27.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Tientcheu D, Ayers C, Das SR, et al. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study. J Am Coll Cardiol. 2015 Nov 17;66(20):2159-2169. doi:10.1016/j.jacc.2015.09.007.</mixed-citation><mixed-citation xml:lang="en">Tientcheu D, Ayers C, Das SR, et al. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study. J Am Coll Cardiol. 2015 Nov 17;66(20):2159-2169. doi:10.1016/j.jacc.2015.09.007.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">da Silva A, Caldas A, Hermsdorff H, et al. Triglyceride‑glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019 Jul 11;18(1):89. doi:10.1186/s12933-019-0893-2.</mixed-citation><mixed-citation xml:lang="en">da Silva A, Caldas A, Hermsdorff H, et al. Triglyceride‑glucose index is associated with symptomatic coronary artery disease in patients in secondary care. Cardiovasc Diabetol. 2019 Jul 11;18(1):89. doi:10.1186/s12933-019-0893-2.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Velagaleti RS, Gona P, Chuang ML, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010 May;3(3):257-63. doi:10.1161/CIRCIMAGING.109.911438. Epub 2010 Mar 5.</mixed-citation><mixed-citation xml:lang="en">Velagaleti RS, Gona P, Chuang ML, et al. Relations of insulin resistance and glycemic abnormalities to cardiovascular magnetic resonance measures of cardiac structure and function: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010 May;3(3):257-63. doi:10.1161/CIRCIMAGING.109.911438. Epub 2010 Mar 5.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Shah RV, Abbasi SA, Heydari B, et al. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013 Apr 23;61(16):1698-706. doi:10.1016/j.jacc.2013.01.053.</mixed-citation><mixed-citation xml:lang="en">Shah RV, Abbasi SA, Heydari B, et al. Insulin resistance, subclinical left ventricular remodeling, and the obesity paradox: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2013 Apr 23;61(16):1698-706. doi:10.1016/j.jacc.2013.01.053.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ho JE, McCabe EL, Wang TJ, et al. Cardiometabolic traits and systolic mechanics in the community. Circ Heart Fail. 2017 May;10(5). pii: e003536. doi:10.1161/CIRCHEARTFAILURE.116.003536.</mixed-citation><mixed-citation xml:lang="en">Ho JE, McCabe EL, Wang TJ, et al. Cardiometabolic traits and systolic mechanics in the community. Circ Heart Fail. 2017 May;10(5). pii: e003536. doi:10.1161/CIRCHEARTFAILURE.116.003536.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Lin JL, Sung KT, Su CH, et al. Cadriac structural remodeling, longitudinal systolic strain and torsional mechanics in lean and nonlean dysglycemic Chinese adults. Circ Cardiovasc Imaging. 2018 May;11(5):e007047. doi:10.1161/CIRCIMAGING.117.007047.</mixed-citation><mixed-citation xml:lang="en">Lin JL, Sung KT, Su CH, et al. Cadriac structural remodeling, longitudinal systolic strain and torsional mechanics in lean and nonlean dysglycemic Chinese adults. Circ Cardiovasc Imaging. 2018 May;11(5):e007047. doi:10.1161/CIRCIMAGING.117.007047.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cauwenberghs N, Knez J, Thijs L, et al. Relation of Insulin Resistance to Longitudinal changes in Left Ventricular Structure and Function in a General Population. J Am Heart Assoc. 2018 Mar 24;7(7). pii: e008315. doi:10.1161/JAHA.117.008315.</mixed-citation><mixed-citation xml:lang="en">Cauwenberghs N, Knez J, Thijs L, et al. Relation of Insulin Resistance to Longitudinal changes in Left Ventricular Structure and Function in a General Population. J Am Heart Assoc. 2018 Mar 24;7(7). pii: e008315. doi:10.1161/JAHA.117.008315.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78.</mixed-citation><mixed-citation xml:lang="en">Baigent C, Keech A, Kearney PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2005;366:1267-78.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Rewers M, Zaccaro D, D’Agostino R, et al. Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:781-7.</mixed-citation><mixed-citation xml:lang="en">Rewers M, Zaccaro D, D’Agostino R, et al. Insulin Resistance Atherosclerosis Study Investigators. Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. Diabetes Care. 2004;27:781-7.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012;7(12):e52036. doi:10.1371/journal.pone.0052036. Epub 2012 Dec 28.</mixed-citation><mixed-citation xml:lang="en">Gast KB, Tjeerdema N, Stijnen T, et al. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS One. 2012;7(12):e52036. doi:10.1371/journal.pone.0052036. Epub 2012 Dec 28.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Rewers M, Zaccaro D, D’Agostino HG, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-17.</mixed-citation><mixed-citation xml:lang="en">Rewers M, Zaccaro D, D’Agostino HG, et al. Insulin sensitivity and atherosclerosis: the Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-17.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Saad MF, Rewers M, Selby J, et al. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension. 2004;43:1324-31.</mixed-citation><mixed-citation xml:lang="en">Saad MF, Rewers M, Selby J, et al. Insulin resistance and hypertension: the Insulin Resistance Atherosclerosis study. Hypertension. 2004;43:1324-31.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Velez M, Kohli S, Sabbah HN. Animal models of insulin resistance and heart failure. Heart Fail Rev. 2014 Jan;19(1):1-13. doi:10.1007/s10741-013-9387-6.</mixed-citation><mixed-citation xml:lang="en">Velez M, Kohli S, Sabbah HN. Animal models of insulin resistance and heart failure. Heart Fail Rev. 2014 Jan;19(1):1-13. doi:10.1007/s10741-013-9387-6.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008 Jan 15;51(2):93-102. doi:10.1016/j.jacc.2007.10.021</mixed-citation><mixed-citation xml:lang="en">Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. J Am Coll Cardiol. 2008 Jan 15;51(2):93-102. doi:10.1016/j.jacc.2007.10.021</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017 Mar 15;113(4):389-398. doi:10.1093/cvr/cvx012.</mixed-citation><mixed-citation xml:lang="en">Nishida K, Otsu K. Inflammation and metabolic cardiomyopathy. Cardiovasc Res. 2017 Mar 15;113(4):389-398. doi:10.1093/cvr/cvx012.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACCF/ACC/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guidelines for the management of heart failure: a report of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi:10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.</mixed-citation><mixed-citation xml:lang="en">Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACCF/ACC/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guidelines for the management of heart failure: a report of the American College of Cardiology Foundation/American HeartAssociation Task Force on Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi:10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
